.

.

more information
.
.

.

more information
.
.

.

more information
.
.

.

more information
.
.

.

more information
.
In Focus

Joint statement on the current epidemics of new Coronavirus

Together with IPOPI, INGID, APSID, ASID, ARAPID, CIS, LASID, SEAPID we have worked on... es

IPOPI – ESID Joint Statement: The use of monoclonal antibody treatment for patients with PID in the context of the COVID-19 pandemic

 IPOPI ESID Statement IPOPI – ESID Joint Statement The use of monoclonal antib... es

ESID COVID-19 Statement, March 2022

Since the start of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) p... es
News

Extended applications deadline for the 2024 IAPIDS Advanced Clinical Immunology Training and Career Building!

... es

Attention ESID Junior members! The Call for ESID Fellowships October 2023 is now open!

... es

Great opportunity for ESID Juniors! Become a GenIA curator!

... es
Events
  • Grand Rounds Webinar May 2022: STOP XLA - Recording is available here

    es
  • ESID Grand Rounds 2021-2022 - Round 2: Managing COVID in patients with Type 1 IFN pathway defects - Video

    es
Shortcuts
Affiliated Societies
Affiliated Societies es
Marseille 2024
ESID 2024 Biennial meeting in Marseille es
Access the Grand Rounds Webinars' recordings here
Access the Grand Rounds Webinars' recordings here es
Registry
ESID Online Registry es
Newsletter
Access ESID’s latest news es